IL99402A0 - 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof - Google Patents

3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof

Info

Publication number
IL99402A0
IL99402A0 IL99402A IL9940291A IL99402A0 IL 99402 A0 IL99402 A0 IL 99402A0 IL 99402 A IL99402 A IL 99402A IL 9940291 A IL9940291 A IL 9940291A IL 99402 A0 IL99402 A0 IL 99402A0
Authority
IL
Israel
Prior art keywords
aryl
pharmaceutical formulations
cck antagonists
quinazolinone
quinazolinone cck
Prior art date
Application number
IL99402A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL99402A0 publication Critical patent/IL99402A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL99402A 1990-09-13 1991-09-04 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof IL99402A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/581,943 US5075313A (en) 1990-09-13 1990-09-13 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof

Publications (1)

Publication Number Publication Date
IL99402A0 true IL99402A0 (en) 1992-08-18

Family

ID=24327210

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99402A IL99402A0 (en) 1990-09-13 1991-09-04 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof

Country Status (20)

Country Link
US (1) US5075313A (cs)
EP (1) EP0475755B1 (cs)
JP (1) JPH04247080A (cs)
KR (1) KR920006350A (cs)
CN (1) CN1059722A (cs)
AU (1) AU641043B2 (cs)
CA (1) CA2050994A1 (cs)
CZ (1) CZ279774B6 (cs)
DE (1) DE69113379T2 (cs)
ES (1) ES2078455T3 (cs)
FI (1) FI914262L (cs)
HU (1) HUT59128A (cs)
IE (1) IE913217A1 (cs)
IL (1) IL99402A0 (cs)
MX (1) MX9101035A (cs)
NO (1) NO913579L (cs)
NZ (1) NZ239712A (cs)
PT (1) PT98915A (cs)
YU (1) YU151691A (cs)
ZA (1) ZA917149B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340801A (en) * 1991-05-08 1994-08-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cholecystokinin and gastrin antagonistic properties
US5204354A (en) * 1992-02-14 1993-04-20 Merck & Co., Inc. Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
DE69318212T2 (de) * 1992-06-05 1998-11-19 Merck Sharp & Dohme Sulfatsalz von einem substituierten Triazol, seine pharmazeutischen Zusammensetzungen und ihre Verwendung in Therapie
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
GB0031315D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Indole derivatives
HU230253B1 (hu) 2001-01-26 2015-11-30 Merck Sharp & Dohme Corp Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
DK1355644T3 (da) 2001-01-26 2006-10-23 Schering Corp Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP2005504091A (ja) 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
CA2517571C (en) 2003-03-07 2011-07-05 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング　コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
US7348338B2 (en) * 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
CA2532403A1 (en) * 2003-07-17 2005-02-03 James Arnold Ppar active compounds
GB0319126D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
JP2008521831A (ja) * 2004-11-30 2008-06-26 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
JP2008521829A (ja) * 2004-11-30 2008-06-26 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
JP2009509932A (ja) * 2005-09-07 2009-03-12 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
BRPI0615948A2 (pt) * 2005-09-07 2011-05-31 Plexxikon Inc composto ativo de ppar, sua composição, seu kit e seu uso
US7893260B2 (en) * 2005-11-04 2011-02-22 Hydra Biosciences, Inc. Substituted quinazolin-4-one compounds for antagonizing TRPV3 function
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
WO2021154966A1 (en) 2020-01-29 2021-08-05 Kamari Pharma Ltd. Compounds and compositions for use in treating skin disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
EP0442878A4 (en) * 1988-04-05 1991-10-23 Abbott Laboratories Derivatives of tryptophan as cck antagonists

Also Published As

Publication number Publication date
NO913579D0 (no) 1991-09-11
CA2050994A1 (en) 1992-03-14
EP0475755A1 (en) 1992-03-18
NZ239712A (en) 1993-06-25
NO913579L (no) 1992-03-16
DE69113379D1 (de) 1995-11-02
CS279991A3 (en) 1992-04-15
JPH04247080A (ja) 1992-09-03
ZA917149B (en) 1992-05-27
FI914262A7 (fi) 1992-03-14
CN1059722A (zh) 1992-03-25
AU641043B2 (en) 1993-09-09
AU8382991A (en) 1992-03-19
FI914262L (fi) 1992-03-14
EP0475755B1 (en) 1995-09-27
KR920006350A (ko) 1992-04-27
YU151691A (sh) 1994-01-20
ES2078455T3 (es) 1995-12-16
DE69113379T2 (de) 1996-03-21
IE913217A1 (en) 1992-02-25
HUT59128A (en) 1992-04-28
PT98915A (pt) 1992-08-31
MX9101035A (es) 1992-05-04
FI914262A0 (fi) 1991-09-10
HU912921D0 (en) 1992-01-28
US5075313A (en) 1991-12-24
CZ279774B6 (cs) 1995-06-14

Similar Documents

Publication Publication Date Title
ZA917149B (en) 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof
IL103621A0 (en) Endothelin receptor antagonists and pharmaceutical compositions containing them
IL99246A0 (en) Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
NZ314184A (en) Substituted quinazoline derivatives and pharmaceutical compositions
EP0490806A3 (en) Nasal pharmaceutical compositions
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
NZ236625A (en) Pyrimidine derivatives and pharmaceutical compositions
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
NZ221184A (en) Quinazoline derivatives and pharmaceutical compositions
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
IL112320A0 (en) Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them
GB9217475D0 (en) Nauroprotective use cck antagonists
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
NZ243627A (en) 3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors
IL105551A0 (en) Quinazolines and pharmaceutical compositions containing them
ZA915372B (en) Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof
NZ237484A (en) Xanthine derivatives and pharmaceutical compositions
NZ239483A (en) Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
HUP9903526A3 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
NZ233121A (en) Substituted thiouracil derivatives and pharmaceutical compositions
ZA911065B (en) Chemical and pharmaceutical compositions
AP9000236A0 (en) Pharmaceutical formulations
NZ233940A (en) Cyclised n-oxo-tetrahydro-beta-carboline derivatives and pharmaceutical compositions thereof
NZ241331A (en) 3-phenyl-2-alkenamide derivatives and pharmaceutical compositions thereof
GB9217154D0 (en) Pharmaceutical compositions and their use